Efficacy and tolerability of veltuzumab + chemotherapy with rituximab + chemotherapy in patients with newly diagnosed follicular lymphoma

Trial Profile

Efficacy and tolerability of veltuzumab + chemotherapy with rituximab + chemotherapy in patients with newly diagnosed follicular lymphoma

Planning
Phase of Trial: Phase III

Latest Information Update: 05 Feb 2010

At a glance

  • Drugs Antineoplastics; Rituximab; Veltuzumab
  • Indications Follicular lymphoma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 05 Feb 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top